Portfolio
Mythic
“Mythic Therapeutics is a product-platform company developing a pipeline of antibody-drug conjugates (ADCs) designed to exhibit unparalleled therapeutic index and efficacy. The Company’s FateControl technology specifically enhances ADC uptake in targeted tissues by manipulating the fate of the ADC within the cell, thereby expanding the disease and patient profiles that can be treated with Mythic’s ADCs.”
Founders: Alex Nichols & Brian Fiske
Location: Boston, Massachusetts
Category: Life Sciences / Therapeutics / Oncology
Company Stage: Series B
Co-Investors: Viking Global, Foresite Capital, Perceptive Advisors, First Round, Lifeforce, OMX, amongst others
